The landscape of dementia prognosis has evolved radically with the advent of innovative biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology yrs before signs and symptoms emerge. Whilst these technological improvements depict amazing development in being familiar with neur